Item 7.01. Regulation FD Disclosure.
On August 8, 2022, Cara Therapeutics, Inc. (the "Company") made available an
updated corporate presentation, which can be found on the Company's website (the
"Corporate Presentation"). The Corporate Presentation is furnished as
Exhibit 99.1 and incorporated by reference in this Item 7.01.
The information furnished under this Item 7.01, including Exhibit 99.1, shall
not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act
of 1934 (the "Exchange Act") or subject to the liabilities of that section, nor
shall it be deemed to be incorporated by reference into any of the Company's
filings with the Securities and Exchange Commission ("SEC") under the Exchange
Act or the Securities Act of 1933, as amended, (the "Securities Act") whether
made before or after the date hereof, regardless of any general incorporation
language in such a filing. The information shall not be deemed incorporated by
reference into any other filing with the SEC made by the Company, regardless of
any general incorporation language in such filing.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits
Exhibit No. Description
99.1 Corporate Presentation, dated August 8, 2022
104 Cover page interactive data file (formatted as Inline XBRL)
1
© Edgar Online, source Glimpses